1
|
Agbaje A, Dakum P, Daniel O, Chukwuma A, Chijoke-Akaniro O, Okpokoro E, Akingbesote S, Anyomi C, Adekunle A, Alege A, Gbadamosi M, Babalola O, Mensah C, Eneogu R, Ihesie A, Adelekan A. Challenges of Screening and Investigations of Contacts of Patients with Tuberculosis in Oyo and Osun States, Nigeria. Trop Med Infect Dis 2024; 9:144. [PMID: 39058186 PMCID: PMC11281629 DOI: 10.3390/tropicalmed9070144] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/30/2024] [Revised: 06/21/2024] [Accepted: 06/22/2024] [Indexed: 07/28/2024] Open
Abstract
Tuberculosis (TB) remains a significant public health challenge in Nigeria, with high rates of transmission and low case detection rates. This paper presents the challenges of screening and investigation of contacts of patients with TB in Oyo and Osun State, Nigeria. This descriptive-qualitative study was conducted in eight Local Government Areas with high TB burdens. Twenty-four focus group discussions and 30 key informant interviews were conducted among TB patients, household TB contacts, and government TB staff, among others. Respondents ages ranged from 17-85 years with a mean of 42.08 ± 14.9 years, and (4.0%) had a postgraduate degree. This study identified that the majority of TB contacts who tested negative for TB were unwilling to be placed on TB preventive therapy because of the belief that only a sick person should take drugs. Also, hostility from the TB contacts to the contact tracers during the house-to-house screening of presumptive TB cases due to community stigma associated with TB was another existing gap reported in TB contact investigations. The findings emphasise the importance of tailored approaches in TB prevention and control, addressing challenges in testing and contact investigations; this necessitates investments in community engagement strategies to enhance the cooperation of TB contacts.
Collapse
Affiliation(s)
- Aderonke Agbaje
- Department of Prevention, Care and Treatment, Institute of Human Virology Nigeria, Abuja 900231, Nigeria; (A.A.); (P.D.); (O.D.); (E.O.); (S.A.); (C.A.); (C.M.)
| | - Patrick Dakum
- Department of Prevention, Care and Treatment, Institute of Human Virology Nigeria, Abuja 900231, Nigeria; (A.A.); (P.D.); (O.D.); (E.O.); (S.A.); (C.A.); (C.M.)
| | - Olugbenga Daniel
- Department of Prevention, Care and Treatment, Institute of Human Virology Nigeria, Abuja 900231, Nigeria; (A.A.); (P.D.); (O.D.); (E.O.); (S.A.); (C.A.); (C.M.)
| | - Anyaike Chukwuma
- Department of Public Health, National Tuberculosis, Leprosy and Buruli Ulcer Control Programme, Federal Ministry of Health, Abuja 900211, Nigeria; (A.C.); (O.C.-A.)
| | - Obioma Chijoke-Akaniro
- Department of Public Health, National Tuberculosis, Leprosy and Buruli Ulcer Control Programme, Federal Ministry of Health, Abuja 900211, Nigeria; (A.C.); (O.C.-A.)
| | - Evaezi Okpokoro
- Department of Prevention, Care and Treatment, Institute of Human Virology Nigeria, Abuja 900231, Nigeria; (A.A.); (P.D.); (O.D.); (E.O.); (S.A.); (C.A.); (C.M.)
| | - Samuel Akingbesote
- Department of Prevention, Care and Treatment, Institute of Human Virology Nigeria, Abuja 900231, Nigeria; (A.A.); (P.D.); (O.D.); (E.O.); (S.A.); (C.A.); (C.M.)
| | - Christian Anyomi
- Department of Prevention, Care and Treatment, Institute of Human Virology Nigeria, Abuja 900231, Nigeria; (A.A.); (P.D.); (O.D.); (E.O.); (S.A.); (C.A.); (C.M.)
| | - Adekola Adekunle
- Department of Prevention, Care and Treatment, Institute of Human Virology Nigeria, Abuja 900231, Nigeria; (A.A.); (P.D.); (O.D.); (E.O.); (S.A.); (C.A.); (C.M.)
| | - Abiola Alege
- Department of Prevention, Care, and Treatment, Society for Family Health, Abuja 900247, Nigeria;
| | - Moroof Gbadamosi
- Department of Public Health, Osun State Ministry of Health, Osogbo 230284, Nigeria;
| | - Olutunde Babalola
- Department of Public Health, Oyo State Ministry of Health, Ibadan 200214, Nigeria;
| | - Charles Mensah
- Department of Prevention, Care and Treatment, Institute of Human Virology Nigeria, Abuja 900231, Nigeria; (A.A.); (P.D.); (O.D.); (E.O.); (S.A.); (C.A.); (C.M.)
| | - Rupert Eneogu
- HIV, AIDS, and TB Unit, United States Agency for International Development, Abuja 900211, Nigeria; (R.E.); (A.I.)
| | - Austin Ihesie
- HIV, AIDS, and TB Unit, United States Agency for International Development, Abuja 900211, Nigeria; (R.E.); (A.I.)
| | - Ademola Adelekan
- Department of Prevention, Care and Treatment, Institute of Human Virology Nigeria, Abuja 900231, Nigeria; (A.A.); (P.D.); (O.D.); (E.O.); (S.A.); (C.A.); (C.M.)
| |
Collapse
|
2
|
Murdoch J, Curran R, van Rensburg AJ, Awotiwon A, Dube A, Bachmann M, Petersen I, Fairall L. Identifying contextual determinants of problems in tuberculosis care provision in South Africa: a theory-generating case study. Infect Dis Poverty 2021; 10:67. [PMID: 33971979 PMCID: PMC8108019 DOI: 10.1186/s40249-021-00840-5] [Citation(s) in RCA: 11] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/20/2021] [Accepted: 04/09/2021] [Indexed: 11/10/2022] Open
Abstract
BACKGROUND Despite progress towards End TB Strategy targets for reducing tuberculosis (TB) incidence and deaths by 2035, South Africa remains among the top ten high-burden tuberculosis countries globally. A large challenge lies in how policies to improve detection, diagnosis and treatment completion interact with social and structural drivers of TB. Detailed understanding and theoretical development of the contextual determinants of problems in TB care is required for developing effective interventions. This article reports findings from the pre-implementation phase of a study of TB care in South Africa, contributing to HeAlth System StrEngThening in Sub-Saharan Africa (ASSET)-a five-year research programme developing and evaluating health system strengthening interventions in sub-Saharan Africa. The study aimed to develop hypothetical propositions regarding contextual determinants of problems in TB care to inform intervention development to reduce TB deaths and incidence whilst ensuring the delivery of quality integrated, person-centred care. METHODS Theory-building case study design using the Context and Implementation of Complex Interventions (CICI) framework to identify contextual determinants of problems in TB care. Between February and November 2019, we used mixed methods in six public-sector primary healthcare facilities and one public-sector hospital serving impoverished urban and rural communities in the Amajuba District of KwaZulu-Natal Province, South Africa. Qualitative data included stakeholder interviews, observations and documentary analysis. Quantitative data included routine data on sputum testing and TB deaths. Data were inductively analysed and mapped onto the seven CICI contextual domains. RESULTS Delayed diagnosis was caused by interactions between fragmented healthcare provision; limited resources; verticalised care; poor TB screening, sputum collection and record-keeping. One nurse responsible for TB care, with limited integration of TB with other conditions, and policy focused on treatment adherence contributed to staff stress and limited consideration of patients' psychosocial needs. Patients were lost to follow up due to discontinuity of information, poverty, employment restrictions and limited support for treatment side-effects. Infection control measures appeared to be compromised by efforts to integrate care. CONCLUSIONS Delayed diagnosis, limited psychosocial support for patients and staff, patients lost to follow-up and inadequate infection control are caused by an interaction between multiple interacting contextual determinants. TB policy needs to resolve tensions between treating TB as epidemic and individually-experienced social problem, supporting interventions which strengthen case detection, infection control and treatment, and also promote person-centred support for healthcare professionals and patients.
Collapse
Affiliation(s)
- Jamie Murdoch
- School of Health Sciences, University of East Anglia, Norwich, NR4 7TJ, UK.
| | - Robyn Curran
- University of Cape Town Lung Institute, Knowledge Translation Unit, University of Cape Town, Mowbray, 7700, South Africa
| | | | - Ajibola Awotiwon
- University of Cape Town Lung Institute, Knowledge Translation Unit, University of Cape Town, Mowbray, 7700, South Africa
| | - Audry Dube
- University of Cape Town Lung Institute, Knowledge Translation Unit, University of Cape Town, Mowbray, 7700, South Africa
| | - Max Bachmann
- Norwich Medical School, University of East Anglia, Norwich, NR4 7TJ, UK
| | - Inge Petersen
- Centre for Rural Health, University of KwaZulu Natal, Durban, South Africa
| | - Lara Fairall
- King's Global Health Institute, King's College London, London, SE1 9NH, UK
- Knowledge Translation Unit, Department of Medicine, University of Cape Town Lung Institute, University of Cape Town, Mowbray, 7700, South Africa
| |
Collapse
|
3
|
Ali SM, Hussain S, Ishaq M, Ali S, Naureen F, Noor A, Rashid A, Anjum N. 3Ts of low cure rate: taxonomy, themes and theory of low cure rate in Pakistan's TB control programme and gathering a 360-degree perspective through qualitative, in-depth interviewing approach. BMJ Open 2019; 9:e025707. [PMID: 31289061 PMCID: PMC6629416 DOI: 10.1136/bmjopen-2018-025707] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/04/2022] Open
Abstract
OBJECTIVE WHO recommends cure of tuberculosis (TB) as the best prevention strategy; however, information about factors associated with low cure rate in patients with drug-susceptible TB is limited in Pakistan. Therefore, the purpose of this study was to explore the factors that account for low TB cure rate. METHODOLOGY The present qualitative study recruited diverse informants through purposive sampling to explore low cure rate situation in Badin between March and June 2017. Data were collected from clinicians, paramedics, lab technicians, district field supervisors, patients and treatment supporters through indepth and face-to-face interviews. Interviews were conducted in local languages (Urdu and Sindhi) and transcribed into English. Coding structure was developed inductively and applied on textual data to draw output at the levels of taxonomy, themes and theory, as proposed by Bradley et al. FINDINGS Thirty-seven individuals consented to participate in this study and provided detailed account of the subject under enquiry. Review of interview data collected from a variety of informants resulted in the identification of four broad factors (taxonomy) that contributed to the situation of low cure rate in one of the districts implementing the public-private mix intervention. These factors were (1) health-seeking behaviour, (2) technical capacity of the healthcare provider, (3) managerial capacity of the healthcare provider, and (4) access to healthcare facility and services. Each factor is deconstructed into key dimensions (themes) that emerged from the dialogue between the interviewer and the respondents. Moreover, dimensions were exemplified through underlying concepts that correspond to theories for low cure rate. CONCLUSION Change in programme reporting requirement has demeaned the significance of having cure as treatment outcome. Therefore, returning the focus to achieving cure status for TB cases will be beneficial for assessing the effectiveness of TB control efforts. In parallel to the care delivery system, a mechanism for disseminating disease-related and treatment-related information should be introduced.
Collapse
Affiliation(s)
- Syed Mustafa Ali
- Monitoring, Evaluation and Research Unit, Mercy Corps Pakistan, Islamabad, Pakistan
| | | | | | | | | | | | | | | |
Collapse
|
4
|
Naidoo P, Theron G, Rangaka MX, Chihota VN, Vaughan L, Brey ZO, Pillay Y. The South African Tuberculosis Care Cascade: Estimated Losses and Methodological Challenges. J Infect Dis 2017; 216:S702-S713. [PMID: 29117342 PMCID: PMC5853316 DOI: 10.1093/infdis/jix335] [Citation(s) in RCA: 164] [Impact Index Per Article: 20.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/20/2022] Open
Abstract
Background While tuberculosis incidence and mortality are declining in South Africa, meeting the goals of the End TB Strategy requires an invigorated programmatic response informed by accurate data. Enumerating the losses at each step in the care cascade enables appropriate targeting of interventions and resources. Methods We estimated the tuberculosis burden; the number and proportion of individuals with tuberculosis who accessed tests, had tuberculosis diagnosed, initiated treatment, and successfully completed treatment for all tuberculosis cases, for those with drug-susceptible tuberculosis (including human immunodeficiency virus (HIV)–coinfected cases) and rifampicin-resistant tuberculosis. Estimates were derived from national electronic tuberculosis register data, laboratory data, and published studies. Results The overall tuberculosis burden was estimated to be 532005 cases (range, 333760–764480 cases), with successful completion of treatment in 53% of cases. Losses occurred at multiple steps: 5% at test access, 13% at diagnosis, 12% at treatment initiation, and 17% at successful treatment completion. Overall losses were similar among all drug-susceptible cases and those with HIV coinfection (54% and 52%, respectively, successfully completed treatment). Losses were substantially higher among rifampicin- resistant cases, with only 22% successfully completing treatment. Conclusion Although the vast majority of individuals with tuberculosis engaged the public health system, just over half were successfully treated. Urgent efforts are required to improve implementation of existing policies and protocols to close gaps in tuberculosis diagnosis, treatment initiation, and successful treatment completion.
Collapse
Affiliation(s)
- Pren Naidoo
- Desmond Tutu TB Centre, Department of Paediatrics and Child Health, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.,Bill and Melinda Gates Foundation, Seattle, Washington
| | - Grant Theron
- DST/NRF Centre of Excellence for Biomedical Tuberculosis Research.,MRC Centre for Tuberculosis Research, Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa
| | - Molebogeng X Rangaka
- Wellcome Centre for Infectious Disease Research in Africa, Institute of Infectious Diseases and Molecular Medicine, University of Cape Town, Cape Town, South Africa.,Institute of Global Health, University College London, London, United Kingdom
| | - Violet N Chihota
- Implementation Research Division, Aurum Institute, Johannesburg, South Africa.,School of Public Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa
| | - Louise Vaughan
- DST/NRF Centre of Excellence for Biomedical Tuberculosis Research.,MRC Centre for Tuberculosis Research, Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa
| | - Zameer O Brey
- Bill and Melinda Gates Foundation, Seattle, Washington
| | - Yogan Pillay
- HIV/AIDS, TB, and Maternal and Child Health Branch, National Department of Health, Pretoria, South Africa
| |
Collapse
|